Regan Zambri Long PLLC
English Español
Call Now 202-960-4596
Menu

U.S. Food and Drug Administration Warnings

08/08/16   |   By

New Salmonella Infection Prompts Calls for Warning Label

Our Washington, DC injury lawyer explains why a warning label may be necessary after a salmonella outbreak compromised the health of people in nine states.

Read More
07/11/16   |   By

Critique of New FDA Product Nutrition Labels

Critics of the suggest that the new FDA product label claim that it places an emphasis on the wrong dietary factors.

Read More
07/11/16   |   By

FDA Product Nutrition Labels Have a New Look

The FDA has completed its overhaul of nutrition labels on packaged foods.

Read More
03/28/14   |   By

In Wake of Pilva V. Mensing, an Uproar: FDA’s New Proposed Rule Would Let Generic Drug Makers Update Their Warning Labels |

In 2012, the U.S. Supreme Court ruled in the case of Pilva, Inc. v. Mensing that the makers of generic pharmaceuticals cannot update their warning labels i

Read More
11/05/13   |   By

FDA Allows Drug Company Representatives to Attend Painkiller Drug Panel | DC Metro Area Medical Malpractice Law Blog

Posted by: Salvatore J. Zambri, founding member and partner   Have drug companies become too close to the organization that is supposed to regulate th

Read More
05/13/13   |   By

FDA Proposes Reclassification of Tanning Beds | DC Metro Area Personal Injury Law Blog

Posted by: Salvatore J. Zambri, founding member and partner   Health risks associated with indoor tanning have been documented for a number of years,

Read More
03/04/13   |   By

FDA Recall: DePuy Orthopaedics Class I Recall for LPS Diaphyseal Sleeve | DC Metro Area Medical Malpractice Law Blog

Posted by Salvatore J. Zambri, founding member and partner   The FDA recently announced a Class 1 Recall for DePuy Orthopedics.  We are reproduci

Read More
02/22/13   |   By

Should Compounding Pharmacies Be Required to Follow FDA Safety Regulations? | DC Metro Area Medical Malpractice Law Blog

Posted by Salvatore J. Zambri, founding member and partner   The International Academy of Compounding Pharmacies has traditionally fought against FDA

Read More
08/02/10   |   By

FDA now investigating second Johnson & Johnson plant in Pennsylvania | DC Metro Area Personal Injury Law Blog

The U.S. Food & Drug Administration is investigating a Johnson & Johnson plant in Lancaster, Pennsylvania, just months after FDA scrutiny led J&J to shut down a plant in Fort Washington, Pennsylvania.  […]

Read More
08/01/10   |   By

J&J expands Motrin, Tylenol, Benadryl recall | DC Metro Area Personal Injury Law Blog

Johnson & Johnson has expanded, to 21 lots, its recall of various over-the-counter medicines in the Tylenol, Motrin, and Benadryl product lines.  The full list of recalled products is here.  […]

Read More

Archives

Schedule a Free Consultation

Have you or your loved one sustained injuries in Washington DC, Maryland or Virginia? Regan Zambri Long PLLC has the best lawyers in the country to analyze your case and answer the questions you may have.

Call 202-960-4596

  • Please do not send any confidential or sensitive information in this form. This form sends information by non-encrypted email, which is not secure. Submitting this form does not create an attorney-client relationship.

  • This field is for validation purposes and should be left unchanged.
Back to Top